Relmada Therapeutics
RLMD
#8408
Rank
โ‚น25.90 B
Marketcap
โ‚น242.77
Share price
-15.76%
Change (1 day)
-36.54%
Change (1 year)

EPS for Relmada Therapeutics (RLMD)

EPS in 2026 (TTM): -โ‚น83.37

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น86.17. In 2025 the company made an earnings per share (EPS) of -โ‚น134.36 an increase over its 2024 EPS that were of -โ‚น245.55.

EPS history for Relmada Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น83.37-37.95%
2025-โ‚น134.36-45.28%
2024-โ‚น245.55-19.21%
2023-โ‚น303.92-38.11%
2022-โ‚น491.10-25.98%
2021-โ‚น663.4587.93%
2020-โ‚น353.0339.05%
2019-โ‚น253.89-4.2%
2018-โ‚น265.0137.5%
2017-โ‚น192.73100%
2016-โ‚น96.37-87.56%
2015-โ‚น774.64
2013-โ‚น2.93273.48%
2012-โ‚น0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cytokinetics
CYTK
-โ‚น559.67 549.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
โ‚น113.05-231.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel